510(k) Report

De Novo · Granted

Granted

Cognivue

DEN130033De NovoGranted Jun 5, 2015723-day reviewClass II21 CFR 882.1470

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cerebral Assessment Systems, Inc. · PKQ Computerized Cognitive Assessment Aid

Granted on Jun 5, 2015 as a new device type through De Novo after a 723-day review. 8 later devices descend from it.

Decided
Jun 5, 2015
Review
723 days
Class
Class II
Product code
PKQ
Recalls
None

8 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2015: 1 descendant cleared2016: 1 descendant cleared2019: 2 descendants cleared2018: 2 descendants cleared2023: 1 descendant cleared2025: 1 descendant cleared201620182020202220242026
  1. This deviceDEN130033 CognivueCerebral Assessment Systems, Inc. · 2015
  2. Descendant · cites it directly · 7 of its ownK150154 ANAM Test System: Military BatteryVista Lifesciences, Inc. · 2015
  3. Descendant · 2 generations on · 6 of its ownK161068 Ahead 300Brainscope Company, Inc. · 2016
  4. Descendant · 3 generations on · 5 of its ownK181179 BrainScope OneBrainscope Company, Inc. · 2018
  5. Descendant · 2 generations on · 3 of its ownK183241 BrainScope TBI (Model: Ahead 400)Brainscope Company, Inc. · 2019
  6. Descendant · 3 generations on · 2 of its ownK190815 BrainScope TBIBrainscope Company, Inc. · 2019

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2015: 12016: 12018: 22019: 22023: 12025: 1
2015high 2 (2018) · low 0 (2017)2026

Most influential descendants

Showing 5 of 8 · See all
  • K150154ANAM Test System: Military BatteryVista Lifesciences, Inc. · 2015 · cites it directly7descendants
  • K161068Ahead 300Brainscope Company, Inc. · 2016 · 2 generations on6descendants
  • K181179BrainScope OneBrainscope Company, Inc. · 2018 · 3 generations on5descendants
  • K183241BrainScope TBI (Model: Ahead 400)Brainscope Company, Inc. · 2019 · 2 generations on3descendants
  • K190815BrainScope TBIBrainscope Company, Inc. · 2019 · 3 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN130033CognivueCerebral Assessment Systems, Inc.2015—
+1K150154ANAM Test System: Military BatteryVista Lifesciences, Inc.2015—
+2K161068Ahead 300Brainscope Company, Inc.2016—
+3K181179BrainScope OneBrainscope Company, Inc.2018—
+2K183241BrainScope TBI (Model: Ahead 400)Brainscope Company, Inc.2019—
+3K190815BrainScope TBIBrainscope Company, Inc.2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
201610
201820
201920
202310
202510
FIG. 1 — Lineage of DEN130033, 2015–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PKQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (8)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K150154ANAM Test System: Military BatteryVista Lifesciences, Inc.20157

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K150154 (Vista Lifesciences, Inc., 2015) has gone furthest, with 7 descendants of its own.

How does its category compare?

All PKQ devices

PKQ Computerized Cognitive Assessment Aid: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · PKQ

1in 2017

2015: 22017: 1
2007high 2 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PKQ

Too few PKQ 510(k)s in any year since 2007 to give a median.

Recalls per year · PKQ

No recall names PKQ since 2007.

Adverse event reports per year · PKQ

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2025

MAUDE reports naming product code PKQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20152—00
20160—00
20171—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

indicated for use as an adjunctive tool for evaluating perceptual and memory function in individuals aged 55-95 years old

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN130033: Cognivue.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN130033

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026